Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: J Subst Abuse Treat. 2014 May 20;47(3):202–212. doi: 10.1016/j.jsat.2014.04.006

Table 3.

Logistic regression odds ratios for retention in buprenorphine treatment at 3 months (n = 294).

Predictor Model 0 Model 1 Model 2 Model 3 Model 4





OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Emerging Adult (compared 10 older adult) 0.37 [0.21–0.66]* 0.39 [0.22–0.70]* 0.36 [0.20–0.66]* 0.41 [0.22–0.75]* 0.44 [0.22–0.89]*
Demographics
 Past-year history of psychiatric medication 1.41 [0.81–2.45] 1.36 [0.77–2.39] 1.44 [0.81–2.56] 1.44 [0.81–2.56]
Recent substance use patterns
 Self-reported use in past 30 days
  Alcohol 2.32 [0.91–5.92] 2.46 [0.95–6.34] 2.36 [0.91–6.10]
 Urine toxicology screening at intake
  Cannabis 0.75 [0.42–1.35] 0.73 [0.40–1.32] 0.70 [0.39–1.29]
  Cocaine 0.38 [0.20–0.74] * 0.42 [0.22–0.81]* 0.42 [0.21–0.81]*
Opioid dependence severity
 Lifetime heroin use 0.81 [0.33–2.00] 0.83 [0.33–2.07]
 History of injection drug use 0.52 [0.25–1.04] 0.42 [0.25–1.03]
Opioid dependence experience
 Total years of opioid use 1.00 [0.96–1.03]
 Short duration of opioid use (< 2 years) 0.38 [0.07–1.99]
*

p < 0.05.

p < 0.10.